QTAS
1 known investors
Qtas develops a quantum-sensor-based microscopy platform, described as the world's smallest MRI, that detects, sorts, and recovers intact individual rare cells (such as circulating tumor cells and rare immune cells) directly from unprocessed biological samples like whole blood or spinal fluid. The platform serves pharma, biotech, and liquid biopsy partners as an upstream tool feeding downstream molecular, genomic, proteomic, and single-cell analysis.
Investors · 1
Frequently asked questions
- What does QTAS do?
- Qtas develops a quantum-sensor-based microscopy platform, described as the world's smallest MRI, that detects, sorts, and recovers intact individual rare cells (such as circulating tumor cells and rare immune cells) directly from unprocessed biological samples like whole blood or spinal fluid. The platform serves pharma, biotech, and liquid biopsy partners as an upstream tool feeding downstream molecular, genomic, proteomic, and single-cell analysis.
- Who are QTAS's investors?
- QTAS's investors include OVNI Capital.